August 23, 2010 09:08 ET

Glucose Monitoring Devices Market to Reach $16 Billion by 2014

ROCKVILLE, MD--(Marketwire - August 23, 2010) - has announced the addition of Renub Research's new report "Glucose Monitoring Devices Market Worldwide (2010 - 2014)" to their collection of Medical Devices market reports. For more information, visit

The report is an essential source of data and analysis on the Blood Glucose Monitoring Devices Market with complete coverage by categories. The key trends shaping and driving the dynamism in the global blood glucose monitoring devices market are covered.

The report provides insight on the emerging key players which are expected to bring a significant shift in the market standing of the existing leaders including Roche, Abbott Laboratories, Bayer AG, Lifescan Inc., Terumo Corporation, Arkray Inc.

Regions covered include the U.S., Europe, India, China, Japan, Malaysia, Taiwan, South Korea, Indonesia, Singapore, Thailand, Philippines, Australia, and the Rest of the World.

Research highlights

  • Worldwide Glucose monitoring devices market is expected to be more than US$ 16 Billion by 2014
  • Roche Diagnostics & Life Scan together controlled 65% of the global glucose meter market in 2008
  • USA's glucose monitoring devices market sales has crossed US$ 2.5 Billion by 2009
  • Europe's glucose monitoring devices market is expected be more than double the USA market by 2014
  • Japan's glucose monitoring devices market is expected to grow with a CAGR of 28.6% for the period of 2010 to 2014
  • India's number of diabetes patients has crossed 50 Million mark by 2010
  • India glucose monitoring devices market is expected to more than US$ 100 Million by 2014
  • China's glucose monitoring devices market is expected to be more than US$ 150 Million by 2014

For more information, visit:

Contact Information